Universal reperfusion therapy can be implemented: Lessons from 20 years of management of patients admitted within 6 hours of symptom onset with ST-segment elevation acute myocardial infarction

Archives of Cardiovascular Diseases

Volumn 102, Issue 4, 2009, Pages 259-267

  Juliard, Jean Michel ^a,f   Golmard, Jean Louis ^b   Ducrocq, Gregory ^a   Himbert, Dominique ^a   Aubry, Pierre ^a   Garbarz, Eric ^a   Benamer, Hakim ^a   Boudvillain, Olivier ^a   Tchétché, Didier ^a   Feldman, Laurent J ^a,f   Burnod, Alexis ^c   Greffet, Agnès ^d   Lapostolle, Frédéric ^e   Steg, Philippe Gabriel ^a,f  

^a BICHAT HOSPITAL   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c BEAUJON HOSPITAL   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e AVICENNE HOSPITAL   (France)

^f INSERM   (France)

Author keywords

Glycoprotein IIb IIIa inhibitors; Myocardial infarction; Primary angioplasty; Stents; Thrombolysis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; DISEASE ASSOCIATION; FEMALE; HEART MUSCLE REPERFUSION; HOSPITAL ADMISSION; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; ST SEGMENT ELEVATION; SYMPTOM;

EID: 67349206973     PISSN: 18752136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acvd.2009.01.006     Document Type: Article

References (39)

1. Rosengren A, Wallentin L, Simoons M, et al. Age, clinical presentation, and outcome of acute coronary syndromes in the Euroheart acute coronary syndrome survey. Eur Heart J 2006;27:789-795
2. Eagle KA, Goodman SG, Avezum A, et al. Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global registry of acute coronary events (GRACE). Lancet 2002;359:373-377 (Pubitemid 34158943)
3. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation 2004;110:588-636.
4. Van de Werf F, Ardissino D, Betriu A, et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The task force on the management of acute myocardial infarction of the european society of cardiology. Eur Heart J 2003;24:28-66. (Pubitemid 36109547)
5. Juliard JM, Steg PG, Himbert D, et al. A patency-oriented strategy for early management of acute myocardial infarction using emergency coronary angiography and selective coronary angioplasty. Am J Cardiol 1992;69:1383-1388
6. Juliard JM, Himbert D, Golmard JL, et al. Can we provide reperfusion therapy to all unselected patients admitted with acute myocardial infarction? J Am Coll Cardiol 1997;30:157-164
7. Antman EM, Morrow DA, McCabe CH, et al. Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. N Engl J Med 2006;354:1477-1488
8. Montalescot G, Borentain M, Payot L, et al. Early versus late administration of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention of acute ST-segment elevation myocardial infarction: a meta-analysis. JAMA 2004;292:362-366 (Pubitemid 38944261)
9. Topol EJ. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the Gusto V randomised trial. Lancet 2001;357:1905-1914 (Pubitemid 32568330)
10. Spaulding C, Henry P, Teiger E, et al. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 2006;355:1093-1104 (Pubitemid 44394916)
11. Eagle KA, Nallamothu BK, Mehta RH, et al. Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go. Eur Heart J 2008;29:609-617
12. Kalla K, Christ G, Karnik R, et al. Implementation of guidelines improves the standard of care: the Viennese registry on reperfusion strategies in ST-elevation myocardial infarction (Vienna STEMI registry). Circulation 2006;113:2398-2405 (Pubitemid 43948047)
13. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003;361:13-20. (Pubitemid 36050955)
14. De Luca G, Suryapranata H, Stone GW, et al. Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. JAMA 2005;293:1759-1765 (Pubitemid 40491302)
15. Chen ZM, Jiang LX, Chen YP, et al. Addition of clopidogrel to aspirin in 45, 852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005;366:1607-1621 (Pubitemid 41552416)
16. Sabatine MS, Cannon CP, Gibson CM, et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med 2005;352:1179-1189 (Pubitemid 40397259)
17. Fox KA, Steg PG, Eagle KA, et al. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA 2007;297:1892-1900
18. Nallamothu B, Fox KA, Kennelly BM, et al. Relationship of treatment delays and mortality in patients undergoing fibrinolysis and primary percutaneous coronary intervention. The global registry of acute coronary events. Heart 2007;93:1552-1555
19. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We emergently revascularize occluded coronaries for cardiogenic shock? N Engl J Med 1999;341:625-634
20. White HD, Assmann SF, Sanborn TA, et al. Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the should we emergently revascularize occluded coronaries for cardiogenic shock (SHOCK) trial. Circulation 2005;112:1992-2001. (Pubitemid 41377419)
21. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. J Am Med Assoc 2006;295:2511-2515 (Pubitemid 43854966)
22. Alexander JH, Reynolds HR, Stebbins AL, et al. Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the Triumph randomized controlled trial. JAMA 2007;297:1657-1666 (Pubitemid 46631624)
23. Meyns B, Dens J, Sergeant P, et al. Initial experiences with the Impella device in patients with cardiogenic shock - Impella support for cardiogenic shock. Thorac Cardiovasc Surg 2003;51:312-317 (Pubitemid 38031386)
24. Steg PG, Bonnefoy E, Chabaud S, et al. Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the Captim randomized clinical trial. Circulation 2003;108:2851-2856 (Pubitemid 37517811)
25. Pfisterer M, Brunner-La Rocca HP, Buser PT, et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 2006;48:2584-2591 (Pubitemid 44881238)
26. Mauri L, Hsieh WH, Massaro JM, et al. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007;356:1020-1029 (Pubitemid 46376802)
27. Stone GW, Moses JW, Ellis SG, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 2007;356:998-1008. (Pubitemid 46376800)
28. Camenzind E, Steg PG, Wijns W. Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern. Circulation 2007;115:1440-1455 [55 discussion]. (Pubitemid 46648381)
29. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial. Lancet 2006;367:569-578 (Pubitemid 43247572)
30. Ellis SG, Tendera M, de Belder MA, et al. Facilitated PCI in patients with ST-elevation myocardial infarction. N Engl J Med 2008;358:2205-2217
31. Di Mario C, Dudek D, Piscione F, et al. Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the combined abciximab reteplase stent study in acute myocardial infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial. Lancet 2008;371:559-568
32. Cantor WJ, Fitchett D, Borgundvagg B, et al. Trial of routine angioplasty and stenting after fibrinolysis to enhance reperfusion in acute myocardial infarction. Chicago: American college of cardiology; 2008.
33. Danchin N, Coste P, Ferrieres J, et al. Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the french registry on acute ST-elevation myocardial infarction (FAST-MI). Circulation 2008;118:268-276
34. Armstrong PW. A comparison of pharmacologic therapy with/without timely coronary intervention versus primary percutaneous intervention early after ST-elevation myocardial infarction: the Which Early ST-elevation myocardial infarction Therapy (WEST) study. Eur Heart J 2006;27:1530-1538 (Pubitemid 43954910)
35. Roger VL, Jacobsen SJ, Weston SA, et al. Trends in the incidence and survival of patients with hospitalized myocardial infarction, Olmsted County, Minnesota, 1979 to 1994. Ann Intern Med 2002;136:341-348
36. Hahn J, Lessard D, Yarzebski J, et al. A community-wide perspective into changing trends in the utilization of diagnostic and interventional procedures in patients hospitalized with acute myocardial infarction. Am Heart J 2007;153:594-605. (Pubitemid 46442808)
37. van Domburg RT, Sonnenschein K, Nieuwlaat R, et al. Sustained benefit 20 years after reperfusion therapy in acute myocardial infarction. J Am Coll Cardiol 2005;46:15-20. (Pubitemid 40905123)
38. Danchin N, Blanchard D, Steg PG, et al. Impact of prehospital thrombolysis for acute myocardial infarction on 1-year outcome: results from the French Nationwide USIC 2000 Registry. Circulation 2004;110:1909-1915
39. Zeymer U, Gitt AK, Junger C, et al. Effect of clopidogrel on 1-year mortality in hospital survivors of acute ST-segment elevation myocardial infarction in clinical practice. Eur Heart J 2006;27:2661-2666 (Pubitemid 44729865)